|
Volumn 8, Issue 4, 2009, Pages 270-272
|
Very high-dose ergocalciferol is effective for correcting vitamin D deficiency in children and young adults with cystic fibrosis
|
Author keywords
Cystic fibrosis; Ergocalciferol; Vitamin D deficiency
|
Indexed keywords
25 HYDROXYVITAMIN D;
ERGOCALCIFEROL;
PANCREAS ENZYME;
ADOLESCENT;
ADULT;
ARTICLE;
BODY MASS;
CHILD;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CYSTIC FIBROSIS;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG RESPONSE;
DRUG SAFETY;
FEMALE;
FORCED EXPIRATORY VOLUME;
HUMAN;
MALE;
PANCREAS INSUFFICIENCY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
RECOMMENDED DRUG DOSE;
TOTAL QUALITY MANAGEMENT;
TREATMENT DURATION;
VITAMIN D DEFICIENCY;
VITAMIN SUPPLEMENTATION;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADULT;
CHILD;
CYSTIC FIBROSIS;
ERGOCALCIFEROLS;
FEMALE;
HUMANS;
MALE;
PROSPECTIVE STUDIES;
TREATMENT OUTCOME;
VITAMIN D DEFICIENCY;
VITAMINS;
YOUNG ADULT;
|
EID: 67649494336
PISSN: 15691993
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jcf.2009.04.004 Document Type: Article |
Times cited : (29)
|
References (8)
|